| Wissenschaftl. Titel | A prospective multi-center non-interventional study describing the effectiveness and safety of biosimilar rituximab (Rixathon®/Riximyo®) administered in combination with CHOP chemotherapy for treatment of patients with previously untreated CD20 positive Diffuse Large B-Cell Lymphoma in current clinical practice. |
| Erkrankung |
Blut:
Non-Hodgkin-Lymphome (NHL), hoch-maligne:
Neu diagnostiziert / de novo
|
| weitere Prüfzentren | |
| Kurzprotokoll | Kurzprotokoll |
erstellt 05.04.2018 Student Studienregister
geändert 17.11.2022 Student Studienregister